132 13F filers hold it · −19 against the quarter before · shares held +7.4%
Holdings of 06/30
Health care sectorNasdaq
132 13F filers hold it · −19 against the quarter before · shares held +7.4%
BlackRock holds 8.4% · −1.7pp on the report before
10/13 estimated earnings
13F filers: 132 · −19 since the quarter before · 06/30 holdings
Famous funds that held Keros Therapeutics in their latest 13F report.
| Fund | Value | Since the quarter before |
|---|---|---|
| Mirae Asset Global ETFS HoldingsKeros Therapeutics KROS · 06/30 holdings | $91.1K | No quarter before |
| Mirae Asset Global InvestmentsKeros Therapeutics KROS · 06/30 holdings | $9,470 | Trimmed −44.3% |
| Holder | ||
|---|---|---|
| BlackRock07/29 | 8.4%1,671,343 sh | −1.7pp |
| BlackRock Portfolio Management07/17 | 5.7%1,122,874 sh | First report |
| Nantahala Capital Management05/15 | 6.9%1,360,419 sh | First report |
| BlackRock04/07 | 10.1%1,990,842 sh | First report |
| Vanguard Group03/27 | 0%0 sh | −5.0pp |
| ExodusPoint Capital Management02/17 | 0.04%13,360 sh | −6.3pp |
| Madison Avenue Partners02/17 | 2.7%823,707 sh | −3.7pp |
| Tang Capital Management02/17 | 0%0 sh | −7.9pp |
| D. E. Shaw02/17 | 3.9%756,156 sh | −1.2pp |
| Vanguard Group01/30 | 5%1,525,355 sh | −1.3pp |
| ExodusPoint Capital Management25/11/18 | 6.3%1,907,899 sh | First report |
| D. E. Shaw25/10/27 | 5.1%1,545,948 sh | First report |
| Tang Capital Management25/10/22 | 7.9%2,418,984 sh | First report |
| Pontifax Management 4 G.P.25/10/16 | 0%0 sh | −11.8pp |
| ADAR1 Capital Management25/10/15 | 0%0 sh | −13.3pp |
| ADAR1 Capital Management25/08/21 | 13.27%5,389,264 sh | +0.0pp |
| Madison Avenue Partners25/05/14 | 6.4%2,614,402 sh | First report |
| ADAR1 Capital Management25/05/12 | 13.27%5,390,964 sh | +0.0pp |
| ADAR1 Capital Management25/05/08 | 13.27%5,390,964 sh | −0.0pp |
| Chase & Co Jpmorgan25/05/05 | 0.2%113,803 sh | −6.1pp |